FORM 3 UNITED STATES SECURITIES AND EXCHANGE...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
Audentes Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN...
Audentes Therapeutics Announces Changes to Senior Management Team - Edward R. Conner, M.D. appointed as Senior...
As filed with the Securities and Exchange Commission on May 10, 2019 Registration No...
Audentes Therapeutics to Participate in the Bank of America Merrill Lynch 2019 Health Care Conference PR...
Table of Contents UNITED STATES SECURITIES...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.